ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.72
0.56%
US Tech 100
17,658.00
0.32%
S&P 500
5,214.08
0.51%
US Dollar vs CAD
1.36815
0.03%
Bitcoin
62,894.70
-0.24%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. Ipsen SA (IPN)

  7. Ipsen SA (IPN) News

IPN

Ipsen (IPN)

Ipsen SA
Date:
Sort by:
 Showing the most relevant articles for your search:EU:IPN
DateTimeSourceHeadlineSymbolCompany
05/07/20247:55AMGlobeNewswire Inc.IPSEN SA. - Modalités de mise à disposition et de consultation des documents préparatoires à l’Assemblée Générale Mixte du 28 mai 2024EU:IPNIpsen SA
05/07/20247:55AMGlobeNewswire Inc.Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2024 Annual General MeetingEU:IPNIpsen SA
05/06/202411:00AMGlobeNewswire Inc.Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital socialEU:IPNIpsen SA
05/06/202411:00AMGlobeNewswire Inc.Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capitalEU:IPNIpsen SA
05/02/202412:30AMGlobeNewswire Inc.Ipsen appoints Keira Driansky as EVP, President of North AmericaEU:IPNIpsen SA
05/02/202412:30AMGlobeNewswire Inc.Ipsen appoints Keira Driansky as EVP, President of North AmericaEU:IPNIpsen SA
05/02/202412:30AMGlobeNewswire Inc.Ipsen nomme Keira Driansky, en qualité de Vice-Présidente Exécutive, et Présidente Amérique du NordEU:IPNIpsen SA
04/24/202412:00AMGlobeNewswire Inc.Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidanceEU:IPNIpsen SA
04/24/202412:00AMGlobeNewswire Inc.Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidanceEU:IPNIpsen SA
04/24/202412:00AMGlobeNewswire Inc.Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l'exercice 2024EU:IPNIpsen SA
04/22/202412:00AMGlobeNewswire Inc.Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseasesEU:IPNIpsen SA
04/22/202412:00AMGlobeNewswire Inc.Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseasesEU:IPNIpsen SA
04/22/202412:00AMGlobeNewswire Inc.Ipsen et Skyhawk Therapeutics annoncent la signature d'un accord de collaboration de recherche visant le ciblage d’ARN dans les maladies neurologiques raresEU:IPNIpsen SA
04/17/202411:00AMGlobeNewswire Inc.Ipsen publishes its 2023 Universal Registration DocumentEU:IPNIpsen SA
04/17/202411:00AMGlobeNewswire Inc.Ipsen publie son Document d’enregistrement universel 2023EU:IPNIpsen SA
04/08/202411:00AMGlobeNewswire Inc.Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital socialEU:IPNIpsen SA
04/08/202411:00AMGlobeNewswire Inc.Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capitalEU:IPNIpsen SA
04/02/202412:00AMGlobeNewswire Inc.Ipsen et Sutro Biopharma annoncent la signature d'un accord exclusif de licence mondiale pour un conjugué anticorps-petite molecule ciblant les tumeurs solidesEU:IPNIpsen SA
04/02/202412:00AMGlobeNewswire Inc.Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumorsEU:IPNIpsen SA
04/02/202412:00AMGlobeNewswire Inc.Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumorsEU:IPNIpsen SA
03/07/202411:00AMGlobeNewswire Inc.Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capitalEU:IPNIpsen SA
03/07/202411:00AMGlobeNewswire Inc.Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital socialEU:IPNIpsen SA
02/15/20243:00AMGlobeNewswire Inc.Ipsen S.A. publie ses comptes consolidés 2023EU:IPNIpsen SA
02/15/20243:00AMGlobeNewswire Inc.Ipsen S.A. publishes its 2023 Consolidated Financial StatementsEU:IPNIpsen SA
02/13/20243:08PMGlobeNewswire Inc.Ipsen reçoit l’approbation de la FDA pour le schéma thérapeutique incluant Onivyde®, un potentiel nouveau traitement de référence en première ligne dans l'adénocarcinome du pancréas métastatiqueEU:IPNIpsen SA
02/13/20243:08PMGlobeNewswire Inc.Ipsen’s Onivyde® regimen, a potential new standard-of-care first-line therapy in metastatic pancreatic adenocarcinoma, approved by FDA  EU:IPNIpsen SA
02/13/20243:08PMGlobeNewswire Inc.Ipsen’s Onivyde® regimen, a potential new standard-of-care first-line therapy in metastatic pancreatic adenocarcinoma, approved by FDA  EU:IPNIpsen SA
02/07/202411:58PMGlobeNewswire Inc.Building on solid FY 2023 results, Ipsen anticipates four launches in 2024EU:IPNIpsen SA
02/07/202411:58PMGlobeNewswire Inc.Après de solides résultats pour l’année 2023, Ipsen anticipe quatre lancements commerciaux en 2024.EU:IPNIpsen SA
02/07/202411:58PMGlobeNewswire Inc.Building on solid FY 2023 results, Ipsen anticipates four launches in 2024EU:IPNIpsen SA
 Showing the most relevant articles for your search:EU:IPN

Your Recent History

USOTC
TXTM
ProText Mobility (PK)
USOTC
EMGE
Emergent Health (PK)
USOTC
SONG
Music Licensing (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
RDAR
Raadr (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
GSTC
Globestar Therapeutics (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
ERHE
ERHC Energy (CE)
USOTC
BABL
Buildablock (PK)
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved